BioCentury | Aug 12, 2013
Company News

iQur infectious news

...7 (FP7) to develop a universal influenza vaccine based on iQur's tandem core vaccine technology. iQur...
...a Phase I trial. iQur said the project is expected to be completed in 2017. iQur's...
...Latvia); 3 P Biopharmaceuticals (Navarra, Spain); and the Institut Catala de La Salut (Catalonia, Spain). iQur Ltd....
Items per page:
1 - 1 of 1
BioCentury | Aug 12, 2013
Company News

iQur infectious news

...7 (FP7) to develop a universal influenza vaccine based on iQur's tandem core vaccine technology. iQur...
...a Phase I trial. iQur said the project is expected to be completed in 2017. iQur's...
...Latvia); 3 P Biopharmaceuticals (Navarra, Spain); and the Institut Catala de La Salut (Catalonia, Spain). iQur Ltd....
Items per page:
1 - 1 of 1